News Articles Tagged: Drug Recalls

Navigating the Pharmaceutical Market: Lessons from Ranitidine HCl Recalls

A look into the market dynamics and challenges faced by pharmaceutical intermediates like Ranitidine HCl, emphasizing the impact of impurity concerns and recalls. Insights for sourcing and manufacturing from NINGBO INNO PHARMCHEM CO.,LTD.

Valsartan Recalls and Patient Safety: What You Need to Know

Stay informed about Valsartan recalls, potential impurities like NDMA, and the importance of patient safety. NINGBO INNO PHARMCHEM CO.,LTD. prioritizes quality in pharmaceutical intermediates.

The Rise and Fall of Ranitidine Hydrochloride: A Pharmaceutical Journey

Explore the history, efficacy, and eventual market withdrawal of Ranitidine Hydrochloride due to NDMA concerns. Learn about its medical uses and the importance of pharmaceutical ingredient safety.

Navigating Drug Recalls: Lessons Learned from Losartan Potassium Contamination

NINGBO INNO PHARMCHEM CO.,LTD. discusses the implications of Losartan Potassium recalls due to impurities, emphasizing the importance of API quality control and supplier vigilance.

The Impact of Recalls on Pharmaceutical Supply Chains: Lessons from Ranitidine Hydrochloride

Analyze the broader implications of drug recalls, using Ranitidine Hydrochloride as a case study. NINGBO INNO PHARMCHEM CO.,LTD. discusses supply chain resilience and risk management in the pharmaceutical sector.

Understanding NDMA in Ranitidine: A Critical Review of Safety and Regulatory Changes

Explore the critical issue of NDMA contamination in Ranitidine, its impact on market availability, and the regulatory responses from health authorities. NINGBO INNO PHARMCHEM CO.,LTD. provides insights into pharmaceutical safety.